Integrated BioPharma (OTCMKTS:INBP) Trading Down 8% – Should You Sell?

Shares of Integrated BioPharma, Inc. (OTCMKTS:INBP) were down 8% during trading on Wednesday . The stock traded as low as $0.23 and last traded at $0.23. Approximately 21,500 shares were traded during trading, an increase of 139% from the average daily volume of 9,011 shares. The stock had previously closed at $0.25.

Integrated BioPharma Price Performance

The business’s fifty day simple moving average is $0.22 and its two-hundred day simple moving average is $0.22. The company has a market cap of $6.92 million, a PE ratio of 23.02 and a beta of 0.67.

Integrated BioPharma (OTCMKTS:INBP) last issued its quarterly earnings results on Friday, September 20th. The company reported $0.01 earnings per share (EPS) for the quarter. Integrated BioPharma had a return on equity of 0.59% and a net margin of 0.22%. The company had revenue of $12.75 million for the quarter.

Integrated BioPharma Company Profile

Integrated BioPharma, Inc, together with its subsidiaries, manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through Contract Manufacturing and Other Nutraceutical Businesses segments. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers.